Leukapheresis Market Research Report by Type (Leukapheresis Devices and Leukapheresis Disposables), Application, End-User, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030- Product Image

Sale

Leukapheresis Market Research Report by Type (Leukapheresis Devices and Leukapheresis Disposables), Application, End-User, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

Report
236 Pages
January 2023
Region: Global
360iResearch™
ID: 5322961

UP TO €855EUR$895USD£754GBP OFF until Mar 31^st 2023

The Global Leukapheresis Market size was estimated at USD 51.30 million in 2022, USD 56.21 million in 2023, and is projected to grow at a CAGR of 9.69% to reach USD 107.58 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Leukapheresis Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Leukapheresis Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Leukapheresis Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Leukapheresis Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Leukapheresis Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market is studied across Leukapheresis Devices and Leukapheresis Disposables. The Leukapheresis Devices is further studied across Centrifugal Devices and Membrane Separators.
Based on Application, the market is studied across Research Applications and Therapeutic Applications.
Based on End-User, the market is studied across Academic & Research Institutes, Blood Component Providers & Blood Centers, Contract Research Organizations, Hospitals & Transfusion Centers, and Pharmaceutical & Biotechnology Companies.
Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Leukapheresis Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Leukapheresis Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Leukapheresis Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Leukapheresis Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Leukapheresis Market, including Allcells, LLC, Asahi Kasei Corporation, Beijing Zksk Technology Co. Ltd., Bioivt, Caltag Medsystems Limited, Charles River Laboratories International, Inc., Discovery Life Sciences, Fresenius Se & Co. Kgaa, Guangzhou Daji Medical Science and Technology Co. Ltd., Haemonetics Corporation, Intelligent Tissue Group, Lonza Group Ag, Macopharma Sa, Medica Spa., Miltenyi Biotec, Precision for Medicine, Inc., Puriblood Medical Co. Ltd., Stemexpress, LLC, Terumo BCT, and Zenbio, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Leukapheresis Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Leukapheresis Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Leukapheresis Market?
4. What is the competitive strategic window for opportunities in the Global Leukapheresis Market?
5. What are the technology trends and regulatory frameworks in the Global Leukapheresis Market?
6. What is the market share of the leading vendors in the Global Leukapheresis Market?
7. What modes and strategic moves are considered suitable for entering the Global Leukapheresis Market?

Frequently Asked Questions about the Global Leukapheresis Market

What is the estimated value of the Global Leukapheresis Market?

The Global Leukapheresis Market was estimated to be valued at $51.3 Million in 2022.

What is the growth rate of the Global Leukapheresis Market?

The growth rate of the Global Leukapheresis Market is 9.6%, with an estimated value of $107.58 Million by 2030.

What is the forecasted size of the Global Leukapheresis Market?

The Global Leukapheresis Market is estimated to be worth $107.58 Million by 2030.

Who are the key companies in the Global Leukapheresis Market?

Key companies in the Global Leukapheresis Market include Allcells, LLC, Asahi Kasei Corporation, Beijing Zksk Technology Co. Ltd., Bioivt, Caltag Medsystems Limited, Charles River Laboratories International, Inc., Discovery Life Sciences, Fresenius Se & Co. Kgaa and Haemonetics Corporation.

Report Attribute	Details
No. of Pages	236
Published	January 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 51.3 Million
Forecasted Market Value ( USD ) by 2030	$ 107.58 Million
Compound Annual Growth Rate	9.6%
Regions Covered	Global
No. of Companies Mentioned	20

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing application in cancer therapy
5.1.1.2. Demand for leukapheresis in clinical research
5.1.1.3. Growth in initiatives for blood donations
5.1.2. Restraints
5.1.2.1. High cost of procedure
5.1.3. Opportunities
5.1.3.1. Focus and investment in R&D activities
5.1.3.2. Leukapheresis for CAR or Adoptive Cell Therapy
5.1.4. Challenges
5.1.4.1. Potential issues related to leukapheresis including discomfort, redness, and bruising
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Leukapheresis Market, by Type
6.1. Introduction
6.2. Leukapheresis Devices
6.3.1. Centrifugal Devices
6.3.2. Membrane Separators
6.3. Leukapheresis Disposables

7. Leukapheresis Market, by Application
7.1. Introduction
7.2. Research Applications
7.3. Therapeutic Applications

8. Leukapheresis Market, by End-User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Blood Component Providers & Blood Centers
8.4. Contract Research Organizations
8.5. Hospitals & Transfusion Centers
8.6. Pharmaceutical & Biotechnology Companies

9. Americas Leukapheresis Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Leukapheresis Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Leukapheresis Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Product Portfolio Analysis, By Key Player
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Allcells, LLC
13.2. Asahi Kasei Corporation
13.3. Beijing Zksk Technology Co. Ltd.
13.4. Bioivt
13.5. Caltag Medsystems Limited
13.6. Charles River Laboratories International, Inc.
13.7. Discovery Life Sciences
13.8. Fresenius Se & Co. Kgaa
13.9. Guangzhou Daji Medical Science and Technology Co. Ltd.
13.10. Haemonetics Corporation
13.11. Intelligent Tissue Group
13.12. Lonza Group Ag
13.13. Macopharma Sa
13.14. Medica Spa.
13.15. Miltenyi Biotec
13.16. Precision for Medicine, Inc.
13.17. Puriblood Medical Co. Ltd.
13.18. Stemexpress, LLC
13.19. Terumo BCT
13.20. Zenbio, Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL LEUKAPHERESIS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL LEUKAPHERESIS MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL LEUKAPHERESIS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL LEUKAPHERESIS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL LEUKAPHERESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LEUKAPHERESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL LEUKAPHERESIS MARKET DYNAMICS
FIGURE 11. GLOBAL LEUKAPHERESIS MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 13. GLOBAL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL LEUKAPHERESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2030
FIGURE 15. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
FIGURE 16. GLOBAL LEUKAPHERESIS MARKET SIZE, BY CENTRIFUGAL DEVICES, 2018-2030 (USD MILLION)
FIGURE 17. GLOBAL LEUKAPHERESIS MARKET SIZE, BY MEMBRANE SEPARATORS, 2018-2030 (USD MILLION)
FIGURE 18. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DISPOSABLES, 2018-2030 (USD MILLION)
FIGURE 19. GLOBAL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 20. GLOBAL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL LEUKAPHERESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 22. GLOBAL LEUKAPHERESIS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
FIGURE 23. GLOBAL LEUKAPHERESIS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
FIGURE 24. GLOBAL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 25. GLOBAL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 26. GLOBAL LEUKAPHERESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
FIGURE 27. GLOBAL LEUKAPHERESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
FIGURE 28. GLOBAL LEUKAPHERESIS MARKET SIZE, BY BLOOD COMPONENT PROVIDERS & BLOOD CENTERS, 2018-2030 (USD MILLION)
FIGURE 29. GLOBAL LEUKAPHERESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
FIGURE 30. GLOBAL LEUKAPHERESIS MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, 2018-2030 (USD MILLION)
FIGURE 31. GLOBAL LEUKAPHERESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
FIGURE 32. AMERICAS LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 33. AMERICAS LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 34. AMERICAS LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 35. AMERICAS LEUKAPHERESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 36. ARGENTINA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 37. BRAZIL LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 38. CANADA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 39. MEXICO LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 40. UNITED STATES LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 41. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 42. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 43. UNITED STATES LEUKAPHERESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 44. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 46. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 47. ASIA-PACIFIC LEUKAPHERESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 48. AUSTRALIA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 49. CHINA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. INDIA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 51. INDONESIA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 52. JAPAN LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 53. MALAYSIA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. PHILIPPINES LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 55. SINGAPORE LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 56. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 57. TAIWAN LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 58. THAILAND LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 59. VIETNAM LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 62. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 64. DENMARK LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 65. EGYPT LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 66. FINLAND LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 67. FRANCE LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 68. GERMANY LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 69. ISRAEL LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 70. ITALY LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 71. NETHERLANDS LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 72. NIGERIA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 73. NORWAY LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 74. POLAND LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 75. QATAR LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 76. RUSSIA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 77. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 78. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 79. SPAIN LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 80. SWEDEN LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 81. SWITZERLAND LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 82. TURKEY LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 83. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 84. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 85. GLOBAL LEUKAPHERESIS MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 86. GLOBAL LEUKAPHERESIS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 87. GLOBAL LEUKAPHERESIS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022List of Tables
TABLE 1. GLOBAL LEUKAPHERESIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL LEUKAPHERESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL LEUKAPHERESIS MARKET SIZE, BY CENTRIFUGAL DEVICES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL LEUKAPHERESIS MARKET SIZE, BY CENTRIFUGAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL LEUKAPHERESIS MARKET SIZE, BY CENTRIFUGAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL LEUKAPHERESIS MARKET SIZE, BY MEMBRANE SEPARATORS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL LEUKAPHERESIS MARKET SIZE, BY MEMBRANE SEPARATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL LEUKAPHERESIS MARKET SIZE, BY MEMBRANE SEPARATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL LEUKAPHERESIS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL LEUKAPHERESIS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL LEUKAPHERESIS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL LEUKAPHERESIS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL LEUKAPHERESIS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL LEUKAPHERESIS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL LEUKAPHERESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL LEUKAPHERESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL LEUKAPHERESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL LEUKAPHERESIS MARKET SIZE, BY BLOOD COMPONENT PROVIDERS & BLOOD CENTERS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL LEUKAPHERESIS MARKET SIZE, BY BLOOD COMPONENT PROVIDERS & BLOOD CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL LEUKAPHERESIS MARKET SIZE, BY BLOOD COMPONENT PROVIDERS & BLOOD CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL LEUKAPHERESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL LEUKAPHERESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL LEUKAPHERESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL LEUKAPHERESIS MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL LEUKAPHERESIS MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL LEUKAPHERESIS MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL LEUKAPHERESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL LEUKAPHERESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL LEUKAPHERESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. CANADA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 56. CANADA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. CANADA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CANADA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. MEXICO LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. MEXICO LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. MEXICO LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. CHINA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 78. CHINA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. CHINA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. CHINA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. INDIA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 82. INDIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. INDIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. INDIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. JAPAN LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 90. JAPAN LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. JAPAN LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. JAPAN LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. THAILAND LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 114. THAILAND LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. THAILAND LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. THAILAND LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. DENMARK LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 127. DENMARK LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. DENMARK LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. DENMARK LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. EGYPT LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 131. EGYPT LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. EGYPT LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. EGYPT LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. FINLAND LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 135. FINLAND LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. FINLAND LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. FINLAND LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. FRANCE LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 139. FRANCE LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. FRANCE LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. FRANCE LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. GERMANY LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 143. GERMANY LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. GERMANY LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. GERMANY LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. ISRAEL LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 147. ISRAEL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. ISRAEL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. ISRAEL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. ITALY LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 151. ITALY LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. ITALY LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. ITALY LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. NETHERLANDS LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 155. NETHERLANDS LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. NIGERIA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 159. NIGERIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. NIGERIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. NORWAY LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 163. NORWAY LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. NORWAY LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. NORWAY LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. POLAND LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 167. POLAND LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. POLAND LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. POLAND LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. QATAR LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 171. QATAR LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 172. QATAR LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. QATAR LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. SPAIN LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 187. SPAIN LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. SPAIN LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. SPAIN LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. SWEDEN LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 191. SWEDEN LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 192. SWEDEN LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. SWEDEN LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. SWITZERLAND LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 195. SWITZERLAND LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 198. TURKEY LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 199. TURKEY LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 200. TURKEY LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. TURKEY LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. GLOBAL LEUKAPHERESIS MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 211. GLOBAL LEUKAPHERESIS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 212. GLOBAL LEUKAPHERESIS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 213. GLOBAL LEUKAPHERESIS MARKET RANKING, BY KEY PLAYER, 2022
TABLE 214. GLOBAL LEUKAPHERESIS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 215. GLOBAL LEUKAPHERESIS MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 216. GLOBAL LEUKAPHERESIS MARKET MERGER & ACQUISITION
TABLE 217. GLOBAL LEUKAPHERESIS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 218. GLOBAL LEUKAPHERESIS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 219. GLOBAL LEUKAPHERESIS MARKET INVESTMENT & FUNDING
TABLE 220. GLOBAL LEUKAPHERESIS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 221. GLOBAL LEUKAPHERESIS MARKET: LICENSE & PRICING